Hankosky ER, Lebrec J, Lee CJ, Dimitriadis GK, et al. Tirzepatide and the 10-year predicted risk of cardiovascular disease and type 2 diabetes in adults with obesity and prediabetes: A post hoc analysis from the three-year SURMOUNT-1 trial. Diabetes Obes Metab 2025 Sep 29. doi: 10.1111/dom.70143.
PMID: 41017451